US HHS Bans Minor Gender Care
Analysis based on 15 articles · First reported Dec 18, 2025 · Last updated Jan 01, 2026
The proposed ban on gender-affirming care for minors by the United States — United States Department of Health and Human Services, if finalized, would significantly impact the healthcare industry, particularly hospitals and medical providers that rely on United States — Medicaid and United States — Medicare funding. Companies like GenderBender LLC and TomboyX, which market related products, also face regulatory scrutiny from the United States — Food and Drug Administration.
The United States — United States Department of Health and Human Services, under the Donald Trump administration, has unveiled a series of regulatory actions aimed at effectively banning gender-affirming care for minors. These proposals include cutting off federal United States — Medicaid and United States — Medicare funding from hospitals that provide such care and prohibiting federal United States — Medicaid dollars from being used for these procedures. Health Secretary Robert F. Kennedy Jr. stated that these 'sex-rejecting procedures rob children of their futures'. The United States — Food and Drug Administration also issued warning letters to companies like GenderBender LLC and TomboyX, marketing chest-binding vests, stating they must be for FDA-approved medical uses. These actions build on broader efforts by the Donald Trump administration and Republicans in Congress to restrict transgender rights, including previous executive orders and proposed legislation. The proposals contradict recommendations from major medical organizations like the American Medical Association and are expected to face legal challenges, though they are likely to intimidate healthcare providers.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard